CH603661A5 - - Google Patents

Info

Publication number
CH603661A5
CH603661A5 CH947876A CH947876A CH603661A5 CH 603661 A5 CH603661 A5 CH 603661A5 CH 947876 A CH947876 A CH 947876A CH 947876 A CH947876 A CH 947876A CH 603661 A5 CH603661 A5 CH 603661A5
Authority
CH
Switzerland
Application number
CH947876A
Inventor
Norman Peter Jensen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH603661A5 publication Critical patent/CH603661A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/68Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings containing halogen
    • C07C63/72Polycyclic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH947876A 1975-07-29 1976-07-23 CH603661A5 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/600,169 US4011326A (en) 1975-07-29 1975-07-29 2-Substituted oxazolo[4,5-b]pyridine anti-inflammatory agents

Publications (1)

Publication Number Publication Date
CH603661A5 true CH603661A5 (enExample) 1978-08-31

Family

ID=24402575

Family Applications (1)

Application Number Title Priority Date Filing Date
CH947876A CH603661A5 (enExample) 1975-07-29 1976-07-23

Country Status (14)

Country Link
US (1) US4011326A (enExample)
JP (1) JPS6037116B2 (enExample)
AU (1) AU505159B2 (enExample)
BE (1) BE844577A (enExample)
CH (1) CH603661A5 (enExample)
DE (1) DE2633905A1 (enExample)
DK (1) DK320276A (enExample)
ES (1) ES450245A1 (enExample)
FR (1) FR2319354A1 (enExample)
GB (1) GB1497985A (enExample)
HU (1) HU172167B (enExample)
NL (1) NL7607794A (enExample)
SE (1) SE431545B (enExample)
ZA (1) ZA764527B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085368Y2 (ja) * 1987-03-05 1996-02-14 日産自動車株式会社 内燃機関のコネクティングロッド
SI0937075T1 (en) * 1996-11-11 2004-06-30 Altana Pharma Ag New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors.
RU2278859C2 (ru) 2001-05-15 2006-06-27 Ф.Хоффманн-Ля Рош Аг Замещенные карбоновыми кислотами оксазоловые производные в качестве ppar-альфа и гамма-активаторов при лечении диабета
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2490152C (en) * 2002-07-03 2009-04-07 F. Hoffmann-La Roche Ag Oxazole derivatives and their use as insulin sensitizers
PT1537091E (pt) * 2002-08-30 2010-11-11 Hoffmann La Roche Novos compostos de 2-ariltiazole como agonistas de ppar-alfa e de ppar-gama
BR0314261A (pt) * 2002-09-12 2005-07-26 Hoffmann La Roche Compostos, processo de preparação de um composto, composição farmacêutica que compreende o mesmo, utilização de um composto, método para tratamento e/ou profilaxia de enfermidades e utilização e/ou método de tratamento
KR100713266B1 (ko) * 2002-11-25 2007-05-04 에프. 호프만-라 로슈 아게 인돌릴 유도체
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935195A (en) * 1969-04-28 1976-01-27 Sterling Drug Inc. 4,4'-Stilbenebis-pyridooxazoles and related optical brighteners and polymeric compositions brightened thereby
FR2148362A1 (en) * 1971-08-11 1973-03-23 Ferlux 2-amino-(4,5-b)-oxazolopyridine cpds - with analgesic,anti-inflammato anticonvulsant,muscle relaxant and diuretic activity
AR208500A1 (es) * 1972-06-14 1977-02-15 Merck & Co Inc Procedimiento para la preparacion de derivados de oxazolo(4,5-b)-piridinas

Also Published As

Publication number Publication date
NL7607794A (nl) 1977-02-01
DE2633905A1 (de) 1977-02-17
BE844577A (fr) 1977-01-28
FR2319354A1 (fr) 1977-02-25
FR2319354B1 (enExample) 1979-07-20
AU505159B2 (en) 1979-11-08
AU1605276A (en) 1978-01-26
GB1497985A (en) 1978-01-12
SE7608037L (sv) 1977-01-30
ES450245A1 (es) 1979-05-16
ZA764527B (en) 1978-03-29
JPS5217495A (en) 1977-02-09
HU172167B (hu) 1978-06-28
JPS6037116B2 (ja) 1985-08-24
DK320276A (da) 1977-01-30
SE431545B (sv) 1984-02-13
US4011326A (en) 1977-03-08

Similar Documents

Publication Publication Date Title
FR2319354B1 (enExample)
JPS5244210U (enExample)
JPS5192240U (enExample)
JPS51143901U (enExample)
FR2335472B1 (enExample)
JPS5428186B2 (enExample)
JPS5264235U (enExample)
JPS5247188U (enExample)
JPS5258780U (enExample)
JPS5262830U (enExample)
JPS522691U (enExample)
JPS5214026U (enExample)
JPS51163699U (enExample)
CH598507A5 (enExample)
CH595491A5 (enExample)
CH600691A5 (enExample)
CH600223A5 (enExample)
CH599896A5 (enExample)
CH599726A5 (enExample)
CH599389B5 (enExample)
CH599038A5 (enExample)
CH598909A5 (enExample)
CH598898A5 (enExample)
CH580695A5 (enExample)
CH600288A5 (enExample)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased